Chander R Raman

age ~63

from Vestavia, AL

Get Report

Also known as:

Chander A Raman

Phone and address:: 3037 English Oaks Cir, Birmingham, AL 35226
2055662658

Connected to:

Chander Raman Phones & Addresses

3037 English Oaks Cir, Vestavia, AL 35226 • 2055662658
Vestavia Hills, AL
New York, NY
Willowbrook, IL
Burr Ridge, IL
Farmington Hills, MI
3037 English Oaks Cir, Vestavia, AL 35226

Work

Company:

The university of alabama at birmingham
Sep 2011
Position:

Professor

Education

Degree:

Doctorates, Doctor of Philosophy
School / High School:

Southern Illinois University School of Medicine
1984 to 1989
Specialities:

Microbiology, Philosophy, Immunology

Skills

Molecular Biology • Immunology • Cell Biology • Cell Culture • Lifesciences • Science • Life Sciences • Biochemistry • Animal Models • Western Blotting • Research • Pcr • Flow Cytometry • Cell • Neuroscience • Protein Chemistry • Cancer

Industries

Research

Resumes

Professor

view source

Location:

Birmingham, AL

Industry:

Research

Work:

The University of Alabama at Birmingham
Professor
The University of Alabama at Birmingham Oct 2007 - Sep 2011
Associate Professor
The University of Alabama at Birmingham Nov 1996 - Sep 2007
Assistant Professor
Loyola University Medical Center Oct 1989 - Sep 1994
Postdoctoral Fellow

Education:

Southern Illinois University School of Medicine 1984 - 1989
Doctorates, Doctor of Philosophy, Microbiology, Philosophy, Immunology Idaho State University College of Business 1982 - 1984
Master of Science, Masters, Microbiology Madras Christian College 1977 - 1980
Bachelors, Bachelor of Science, Zoology Rishi Valley School 1971 - 1976

Skills:

Molecular Biology
Immunology
Cell Biology
Cell Culture
Lifesciences
Science
Life Sciences
Biochemistry
Animal Models
Western Blotting
Research
Pcr
Flow Cytometry
Cell
Neuroscience
Protein Chemistry
Cancer

Us Patents

Markers For Determination Of Patient Responsiveness
view source
US Patent:

20110250206, Oct 13, 2011
Filed:

Feb 11, 2011
Appl. No.:

13/026181
Inventors:

Robert C. Axtell - Menlo Park CA, US
Lawrence Steinman - Stanford CA, US
May H. Han - Menlo Park CA, US
Brigit A. de Jong - Nijmegen, NL
Chander Raman - Birmingham AL, US
Michael Walker - Carlsbad CA, US
Jing Shi - Carlsbad CA, US
Tito A. Serafini - Belmont CA, US
International Classification:

A61K 39/395
A61P 3/10
A61P 11/06
G06F 19/00
A61P 1/16
A61P 25/16
A61P 9/10
A61P 3/04
A61P 29/00
A61P 11/00
US Classification:

4241421, 4241451, 702 19
Abstract:

Compositions and methods are provided for prognostic classification of inflammatory diseases, e.g. inflammatory demyelinating disease, patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest. The patterns of cytokines provides for a signature pattern that can identify patients likely to benefit from therapeutic intervention as well as discriminate patients that have a high probability of responsiveness to a therapy from those that have a low probability of responsiveness. Assessment of this signature pattern thus allows improved methods of care. In one embodiment of the invention, the autoimmune disease is multiple sclerosis or neuromyelitis optica.

Markers For Determination Of Patient Responsiveness
view source
US Patent:

20110243893, Oct 6, 2011
Filed:

Feb 11, 2011
Appl. No.:

13/026173
Inventors:

Robert C. Axtell - Menlo Park CA, US
Lawrence Steinman - Stanford CA, US
May H. Han - Menlo Park CA, US
Brigit A. de Jong - Nijmegen, NL
Chander Raman - Birmingham AL, US
Michael Walker - Carlsbad CA, US
Jing Shi - Carlsbad CA, US
International Classification:

A61K 38/21
A61K 38/02
A61K 31/225
A61K 39/395
A61P 29/00
A61P 25/00
G06F 19/00
US Classification:

424 856, 514 11, 514547, 4241421, 702 19
Abstract:

Compositions and methods are provided for prognostic classification of inflammatory diseases, e.g. inflammatory demyelinating disease, patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest. The patterns of cytokines provides for a signature pattern that can identify patients likely to benefit from therapeutic intervention as well as discriminate patients that have a high probability of responsiveness to a therapy from those that have a low probability of responsiveness. Assessment of this signature pattern thus allows improved methods of care. In one embodiment of the invention, the autoimmune disease is multiple sclerosis or neuromyelitis optica.